Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04021212
What this trial is testing

Pituitary Adenoma and Serum Lipid

Who this might be right for
Pituitary Adenoma 1, Acth-Secreting
Shandong Provincial Hospital 1,000
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00003775
What this trial is testing

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT00014300
What this trial is testing

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 32
Early research (Phase 1)Ended earlyNCT00006773
What this trial is testing

Bortezomib in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT05095766
What this trial is testing

Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis

Who this might be right for
Brain Metastases, Adult
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 40
Testing effectiveness (Phase 2)Study completedNCT00107237
What this trial is testing

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Novartis Pharmaceuticals 16
Not applicableLooking for participantsNCT04863612
What this trial is testing

SBRT in the Management of Solid Spinal Metastases

Who this might be right for
Extradural TumorSpinal Metastases
Universitaire Ziekenhuizen KU Leuven 100
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Very early researchNot Yet RecruitingNCT03763396
What this trial is testing

Azoles Targeting Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, RecurrentCancer, AdvancedGlioma of Brain
University Health Network, Toronto 30
Not applicableActive Not RecruitingNCT03398915
What this trial is testing

The European Robotic Spinal Instrumentation (EUROSPIN) Study

Who this might be right for
Degenerative Disc DiseaseSpondylolisthesisSpinal Stenosis+4 more
Marc Schröder 932
Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82
Not applicableStudy completedNCT03626896
What this trial is testing

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma MultiformeBrain TumorGlioblastoma+3 more
NaviFUS Corporation 6
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Large-scale testing (Phase 3)Looking for participantsNCT03418961
What this trial is testing

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Who this might be right for
CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more
SWOG Cancer Research Network 491
Early research (Phase 1)Ended earlyNCT01122888
What this trial is testing

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT03087591
What this trial is testing

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more
Wake Forest University Health Sciences 11
Early research (Phase 1)Ended earlyNCT02648633
What this trial is testing

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Virginia 4
Early research (Phase 1)Looking for participantsNCT05184816
What this trial is testing

Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal Metastases
Memorial Sloan Kettering Cancer Center 32
Early research (Phase 1)UnknownNCT00002647
What this trial is testing

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Medical College of Wisconsin 24
Next Page